Ameriprise’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-36,198
| Closed | -$1.63M | – | 3868 |
|
|
2024
Q1 | $1.63M | Buy |
36,198
+2,381
| +7% | +$107K | ﹤0.01% | 2971 |
|
|
2023
Q4 | $1.6M | Sell |
33,817
-7,956
| -19% | -$376K | ﹤0.01% | 2986 |
|
|
2023
Q3 | $1.69M | Buy |
41,773
+19,932
| +91% | +$807K | ﹤0.01% | 2902 |
|
|
2023
Q2 | $2.33M | Buy |
+21,841
| New | +$2.33M | ﹤0.01% | 2800 |
|